<DOC>
	<DOC>NCT00270972</DOC>
	<brief_summary>This study was designed to confirm the clinical benefits and safety of OrCel in the treatment of venous ulcers. OrCel and standard care are compared to standard care alone. Standard care consists of currently accepted compression therapy. Patients are treated for 12 weeks. Patients with healed ulcers are followed for an additional 12 weeks to assess durability of the healed wound.</brief_summary>
	<brief_title>The Evaluation of OrCel for the Treatment of Venous Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Venous Insufficiency</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Any race, between 18 and 85 years of age Male or female Chronic venous insufficiency Ulcer size between 2 and 20 sq cm, inclusive Ulcer present for at least one month ABI &gt;0.7 Decrease in wound size &gt;35% during Screening Phase Infection at ulcer site Uncontrolled diabetes mellitus Malnutrition Previous treatment with excluded medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Venous leg ulcer</keyword>
	<keyword>Venous insufficiency</keyword>
	<keyword>OrCel</keyword>
</DOC>